The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

RSV season is upon us, which means thousands of children under five years of age and hundreds of thousands of adults will be ...

A research team at the University of Wisconsin-Madison produced high-resolution images of RSV structure, important for RSV ...

Coughing, sneezing, and high temperature are common signs of a cold. While these may look harmless, they can also be symptoms ...

In three months, the distribution of RSV vaccines will begin in the Americas, according to a PAHO announcement.

RSV is a virus that can make people sick, especially older adults and babies. But even though RSV can be serious, people aren't as worried about it anymore. RSV is common but can be dangerous ...

For adults aged 60 years or older, respiratory syncytial virus (RSV) vaccination is effective for preventing associat ...

Despite the recent string of above average temperatures, Dr. Yajnik said the number of RSV patients she’s beginning to see is ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

Moderna said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years ...